Oral versions of GLP-1s have also been approved, though they thus far have lower efficacy
Effective weight loss fills this gap in cardiovascular protection
The math behind every concentration For researchers who want to understand the formulas rather than just follow charts, here is the complete mathematical framework
It is crucial for healthcare providers to carefully consider these dosages, as compounded medications lack the standardized testing of commercially available products, necessitating vigilant monitoring for efficacy and safety
In May, the MHRA and the ASA published an Enforcement Notice which makes clear to businesses which offer vitamin shots the nature of the rulings and directs them to remove any COVID-19 related claims from their websites and social media pages
Q2 2025 Snapshot Eli Lilly and Company dominates the US 57 % GLP-1 share, led by Mounjaro (tirzepatide) HCP & Zepbound (tirzepatide) HCP Novo Nordisk rules Europe 63 % value share, powered by Wegovy(semaglutide) injection 2.4 mg HCP & Ozempic APAC & Emerging Markets are the next frontier (+1113 % YoY) Together, they crossed $24 Billion in H1 2025 GLP-1 revenue proving the real blockbuster of this decade isnt oncology or immunology Its metabolic health